S. Mayock

In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations

A. Fleming, S. Saim, S. Mayock, 2017, Clinical Drug Investigation.

Evaluation of an Extended‐Release, Abuse‐Deterrent, Microsphere‐in‐Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD)

E. Kopecky, A. Fleming, S. Saim, 2016, Pain practice : the official journal of World Institute of Pain.

The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance

Vivian Gray, Saji Thomas, Min Xia, 2009, Pharmaceutical Research.

Oxycodone DETERx, an extended-release, tamper-resistant formulation for management of chronic pain

E. Kopecky, A. Fleming, S. Saim, 2013 .

A review of in vivo and in vitro aspects of alcohol-induced dose dumping

Alger D. Salt, Susan D'Souza, S. Mayock, 2017, AAPS Open.

A review of in vivo and in vitro aspects of alcohol-induced dose dumping

Alger D. Salt, Susan D'Souza, S. Mayock, 2017 .

Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation.

E. Kopecky, P. Noonan, A. Fleming, 2014, Journal of opioid management.

AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle: A Commentary

Susan D'Souza, R. Lozano, V. Gray, 2010 .